|本期目录/Table of Contents|

[1]林永娟,冯契,俞婷婷,等.椎动脉狭窄血管成形术后支架内再狭窄危险因素相关性研究[J].医学研究与战创伤救治(原医学研究生学报),2017,19(02):136-140.[doi:10.3969/j.issn.1672-271X.2017.02.006]
　LIN Yong-juan,FENG Jie,YU Ting-ting,et al.Risk factors ofrestenosis in postoperative patients with vertebral artery stenosis treated by endovascular stent implantation[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2017,19(02):136-140.[doi:10.3969/j.issn.1672-271X.2017.02.006]
点击复制

椎动脉狭窄血管成形术后支架内再狭窄危险因素相关性研究()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第19卷
期数:
2017年02期
页码:
136-140
栏目:
出版日期:
2017-03-20

文章信息/Info

Title:
Risk factors ofrestenosis in postoperative patients with vertebral artery stenosis treated by endovascular stent implantation
作者:
林永娟; 冯契; 俞婷婷; 谢宇; 黄明敏; 郭爱斌; 尹震宇
210009南京，南京大学附属鼓楼医院老年科
Author(s):
LIN Yong-juan; FENG Jie;  YU Ting-ting;  XIE Yu;  HUANG Ming-min;  GUO Ai-bin;  YIN Zhen-yu
(Department of Geriatrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210009, Jiangsu, China)
关键词:
椎动脉粥样硬化; 血管成形术; 支架内再狭窄; 终点事件
Keywords:
Atherosclerosis;  Vertebral artery stents;  Postoperative restenosis;  Risk factors
分类号:
R743
DOI:
10.3969/j.issn.1672-271X.2017.02.006
文献标志码:
A
摘要:
目的 探讨椎动脉粥样硬化性狭窄患者血管内支架置入术后再狭窄的危险因素，研究再狭窄患者预后。方法 选择南京鼓楼医院2004-2013年间收治的椎动脉粥样硬化性狭窄患者173例，均行血管内支架置入术，术后随访（55.7±17.31）个月，记录其性别、年龄、合并症、吸烟史、病变部位、术前术后椎动脉直径、支架类型、支架直径、支架长度等，分析血管内支架置入术后再狭窄的危险因素以及再狭窄预后。结果 所有患者顺利完成血管内支架置入术，随访期间28例出现再狭窄，145例未出现再狭窄，再狭窄发生率为16.2%。2组患者性别、年龄、随访时间、糖尿病、高尿酸血症、冠心病、血管直径、支架类型差异均无统计学意义（P＞0.05）；而再狭窄组高血压、高脂血症、吸烟、和颅外V1段、颅内V4段支架植入位置均明显高于非再狭窄组（P＜0.05）。多因素logistics回归分析显示，高脂血症（HR：4.31,95%CI: 2.99～18.76, P=0.042）为再狭窄危险因素。再狭窄组卒中发生风险明显高于非再狭窄，Kaplan-Meier分析结果 显示，再狭窄组卒中终点事件风险高（OR: 0.141, 95%CI: 0.016～1.221,P=0.029），差异有统计学意义。结论 椎动脉起始部粥样硬化性狭窄患者血管内支架置入术后再狭窄发生率较高，高脂血症是再狭窄独立危险因素，再狭窄患者发生卒中事件风险高。
Abstract:
Objective To investigate the risk factors and restenosis prognosis of restenosis in postoperative patients with atherosclerotic vertebral artery stenosis treated by endovascular stent implantation.Methods A total of 173 patients with atherosclerotic vertebral artery stenosis were selected in the Nanjing Drum Tower Hospital from 2004 to 2013, and all of them were treated by endovascular stent implantation and were followed up for (55.7±17.31). Clinical data including gender, age, complications, smoking history, stent region, preoperative and postoperative diameter of vertebral artery, stent types, stent diameter, stent length and postoperative stenosis length were collected, and the risk factors and restenosis prognosis of restenosis in postoperative patients with atherosclerotic vertebral artery stenosis treated by endovascular stent implantation were analyzed.Results All of the 173 patients successfully completed the endovascular stent implantation, including 28 cases with restenosis, and other 145 cases without restenosis, and the incidence of restenosis was 16.2%. No statistically significant difference of gender, age, time of follow up, incidence of hyperuricemia, diabetes, coronary artey disease, stent diameter,stent types was found between two groups (P>0.05) ; positive rate of smoking history, high blood pressure and hyperlipemia and the stent region of restenosis group was statistically significantly higher than that of the control group (P<0.05); Multivariate logistic regression analysis Results showed that hyperlipemia (HR:4.31, 95% CI: 2.99-18.76, P=0.042) was the only risk factor of restenosis in postoperative patients with atherosclerotic vertebral artery stenosis treated by endovascular stent implantation. The Results of Kaplan-Meier showed that recurrent ischemic events were associated with in-stent restenosis (OR: 0.141, 95% CI: 0.016-1.221, P=0.029).Conclusion The incidence of restenosis is relatively high in postoperative patients with atherosclerotic vertebral artery stenosis treated by endovascular stent implantation, and hyperlipemia is the risk factor, while recur-rent ischemic events are associated with restenosis.

参考文献/References:

[1]Borhani Haghighi A, Edgell RC, Cruz-Flores S, et al. Vertebral artery origin stenosis and its treatment[J]. J Stroke Cerebrovasc Dis, 2011,20(4):369-376.
[2]Brott TG, Halperin JL, Abbara S, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Developed in collaboration with the American Academy of Neurology and Society of Cardiovascular Computed Tomography[J].Catheter Cardiovasc Interv, 2013,81(1):E76-123.
[3]Gupta R, Sivapatham T, Moskowitz SI, et al. Stenting of a symptomatic long-segment extracranial vertebral artery occlusion[J]. J Neurointerv Surg, 2011,3(1):54-56.
[4]Annette C,Bart VW,Wouter JS, et al.Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trail[J].Lancet Neurol, 2015,14(6): 606-614.
[5]Broussalis E,Kun NZ, Luthring SH, et al. Treatment of vertebral artery origin stenosis with a Pharos stent device: a single .center experience[J].Interv Neuroradiol, 2011,17(3): 316-322.
[6]Kocak B.Endovascular treatment of extracranial vertebral artery stenosis[J]. World J Radiol, 2012,4(9):391.
[7]Mousa AY, AbuRahma AF, Bozzay J, et al.Anatomic and clinical predictors of reintervention after subclavian artery stenting[J]. J Vasc Surg,2015,62(1):106-114.
[8]Edgell RC, Zaidat OO, Gupta R, et al. Multicenter study of safety in stenting for symptomatic vertebral artery origin stenosis: results from the Society of Vascular and Interventional Neurology Research Consortium[J].J Neuroimaging, 2013,23(2):170-174.
[9]Gao P, Wang D, Zhao Z, et al. Multicenter prospective trial of stent placement in patients with symptomatic high-grade intracranial stenosis[J]. Am J Neuroradiol, 2016,37(7):1275-1280.
[10]Mohammadian R, Sharifipour E, Mansourizadeh R, et al. Angioplasty and stenting of symptomatic vertebral artery stenosis. Clinical and angiographic follow-up of 206 cases from Northwest Iran[J].Neuroradiol J, 2013,26(4):454-463.
[11]North American Symptomatic Carotid Endarterectomy Collaborators,Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis[J].N Engl J Med,1991,325(7):445-453.
[12]Mokin M, Dumont TM, Kass-Hout T, et al. Carotid and vertebral artery disease[J].Primary care, 2013,40(3):135-151.
[13]Musialek P, Langwieser N. Commentary: vertebral artery ostial stenosis stenting technique: the concept reversed?[J] J Endovasc Ther, 2015,22(3):445-448.
[14]Chen X, Huang Q, Hong B, et al. Drug-eluting stent for the treatment of symptomatic vertebral origin stenosis: Long-term results[J].J Clin Neurosci, 2011,18(1):47-51.
[15]Chaturvedi S, Bhattacharya P. Large artery atherosclerosis: carotid stenosis, vertebral artery disease, and intracranial atherosclerosis[J]. Continuum, 2014,20(2):323-334.
[16]Wang L, Shi W, Su Z, et al. Endovascular treatment of severe acute basilar artery occlusion[J].J Clin Neurosci,2015,22(1):195-198.
[17]Feng H, Xie Y, Mei B, et al. Endovascular vs. medical therapy in symptomatic vertebral artery stenosis: a meta-analysis[J].J Neurol, 2016,20(1):415-326.
[18]Zhong C. Influence of stent-assisted angioplasty on cognitive function and affective disorder in elderly patients with symptomatic vertebrobasilar artery stenosis[J].Med Sci Monit,2014，20(1):1129-1136.
[19]Baek JH, Kim BM. Stenting for symptomatic vertebral artery stenosis associated with bilateral carotid rete mirabile: the long-term clinical and angiographic outcome[J].Korean J Radiol， 2015,16(3):678-681.
[20]Antoniou GA, Murray D, Georgiadis GS, et al. Percutaneous transluminal angioplasty and stenting in patients with proximal vertebral artery stenosis[J]. J Vasc Surg,2012,55(4):1167-1177.
[21]Gross BA, Albuquerque FC. Stenting Versus Aggressive Medical Management for Symptomatic Vertebral Artery Stenosis[J].World Neurosurg,2015,84(3):613-615.
[22]Rangel-Castilla L, Gandhi S, Munich SA, et al. Experience with vertebral artery origin stenting and ostium dilatation: results of treatment and clinical outcomes[J].J Neurointerv Surg, 2016,8(5):476-480.
[23]Jiang Y, Xu X, Wen Z, et al. In-stent restenosis after vertebral artery stenting[J].Int J Cardiol, 2015,187:430-433.
[24]Lu H, Zheng P, Zhang W. Long-term outcome of drug-eluting stenting for stenoses of the intracranial vertebrobasilar artery and vertebral ostium[J]. J Neurointerv Surg, 2013,5(5):435-439.
[25]杨建军，宋雪丹，陈海英，等.血管内支架成形术治疗颅内血管狭窄临床分析[J].东南国防医药,2009，11(2)：33-37.
[26]Li Z, Zhang Y, Hong B, et al. Stenting of symptomatic vertebral artery ostium stenosis with self-expanding stents[J].J Clin Neurosci, 2014,21(2):274-277.
[27]Lin YJ, Li JW, Zhang MJ, et al. The association between CYP2C19 genotype and of in-stent restenosis among patients with vertebral artery stent treatment[J].CNS Neurosci Ther, 2014,20(2):125-130.
[28]Stayman AN, Nogueira RG, Gupta R. A Systematic Review of Stenting and Angioplasty of Symptomatic Extracranial Vertebral Artery Stenosis[J]. Stroke, 2011,42(8):2212-2216.
[29]Tank VH, Ghosh R, Gupta V, et al. Drug eluting stents versus bare metal stents for the treatment of extracranial vertebral artery disease: a meta-analysis[J].J Neurointerv Surg, 2016,8(8):770-774.
[30]Ogilvy CS, Yang X, Natarajan SK, et al. Restenosis rates following vertebral artery origin stenting: does stent type make a difference?[J]J Invasive Cardiol, 2010,22(3):119-124.
[31]林敏,范进,陈光辉.动脉粥样硬化性椎动脉狭窄介入治疗的实践与指南[J].医学研究生学报,2011,24（7）:758-762.
[32]Sun X, Ma N, Wang B, et al. The long term results of vertebral artery ostium stenting in a single center: Table 1[J].J Neurointerv Surg, 2015,7(12):888-891.
[33]Langwieser N, Prothmann S, Buyer D, et al. Safety and efficacy of different stent types for the endovascular therapy of extracranial vertebral artery disease[J].Clin Res Cardiol, 2014,103(5):353-362.
[34]Hatano T, Tsukahara T, Miyakoshi A, et al. Stent placement for atherosclerotic stenosis of the vertebral artery ostium: angiographic and clinical outcomes in 117 consecutive patients[J]. Neurosurgery, 2011,68(1):108-116.

相似文献/References:

[1]杨建军,宋雪丹,陈海英,等.血管内支架成形术治疗颅内血管狭窄 临床分析[J].医学研究与战创伤救治(原医学研究生学报),2009,11(02):112.
　YANG Jian-jun,SONG Xue-dan,CHEN Hai-ying,et al.Endovascular stent-assisted angioplasty for intracranial atherosclerotic stenosis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2009,11(02):112.

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2017-03-20